Volume 43, Issue 1 1 pp. 242-251
Original Scientific Report

Time to Readmission and Mortality Among Patients Undergoing Liver and Pancreatic Surgery

Qinyu Chen

Qinyu Chen

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Fabio Bagante

Fabio Bagante

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Department of Surgery, University of Verona, Verona, Italy

Search for more papers by this author
Griffin Olsen

Griffin Olsen

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Katiuscha Merath

Katiuscha Merath

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Jay J. Idrees

Jay J. Idrees

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Eliza W. Beal

Eliza W. Beal

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Ozgur Akgul

Ozgur Akgul

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Jordan Cloyd

Jordan Cloyd

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Mary Dillhoff

Mary Dillhoff

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Carl Schmidt

Carl Schmidt

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Susan White

Susan White

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Search for more papers by this author
Timothy M. Pawlik

Corresponding Author

Timothy M. Pawlik

Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

Department of Surgery, Oncology, Health Services Management and Policy, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center, 395 W. 12th Ave., Suite 670, Columbus, OH, USA

Tel.: 614 293 8701, [email protected]Search for more papers by this author
First published: 14 August 2018
Citations: 6

Qinyu Chen and Fabio Bagante have contributed equally to this work.

Electronic supplementary material: The online version of this article (https://doi.org/10.1007/s00268-018-4766-8) contains supplementary material, which is available to authorized users.

Abstract

Background

The impact of time to readmission (TTR) on post-discharge mortality has not been well examined. We sought to define the impact of TTR on postoperative mortality after liver or pancreas surgery.

Methods

A retrospective cohort analysis of liver and pancreas surgical patients was conducted using 2013–2015 Medicare Provider Analysis and Review database. Patients were subdivided into TTR groups: 1–5 days, 6–15, 15–30, 31–60, 61–90, and no readmission. The association of index complication, readmission causes, TTR, and mortality was assessed.

Results

Among 18,177 patients, a total of 4485 (24.7%) patients were readmitted within 90 days of discharge. Major causes for readmission differed across TTR groups. Patients readmitted within 1–15 days were more likely to be readmitted for postoperative infection compared with patients who had a late readmission (1–5 days: 63.1% vs. 6–15 days: 65.0% vs. 61–90 days: 39.3%; P < 0.001). In contrast, causes of late readmissions were more likely related to gastrointestinal complications (1–5 days: 28.9% vs. 61–90 days: 39.7%; P < 0.001). Compared with no readmission, 180-day mortality was highest among patients readmitted within 16–30 days (aOR 3.60; 95% CI 2.94–4.41). Among patients with index complications, patients who were readmitted within 1–5 days had a higher risk-adjusted 180-day mortality than late readmission (1–5 days: 37.3% vs. 61–90 days: 27.1%) (P < 0.001).

Conclusions

Among patients who were readmitted, the incidence of mortality increased with TTR up to 60 days after discharge yet decreased thereafter. The relation of TTR and mortality was particularly pronounced among those patients who had an index complication. Future efforts should consider TTR when identifying specific approaches to decrease readmission.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.